160 related articles for article (PubMed ID: 27588488)
1. HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.
Mehta M; Basalingappa K; Griffith JN; Andrade D; Babu A; Amreddy N; Muralidharan R; Gorospe M; Herman T; Ding WQ; Ramesh R; Munshi A
Oncotarget; 2016 Oct; 7(40):64820-64835. PubMed ID: 27588488
[TBL] [Abstract][Full Text] [Related]
2. MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR.
Chaudhary S; Appadurai MI; Maurya SK; Nallasamy P; Marimuthu S; Shah A; Atri P; Ramakanth CV; Lele SM; Seshacharyulu P; Ponnusamy MP; Nasser MW; Ganti AK; Batra SK; Lakshmanan I
Breast Cancer Res; 2023 Mar; 25(1):25. PubMed ID: 36918912
[TBL] [Abstract][Full Text] [Related]
3. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells.
Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR
BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585
[TBL] [Abstract][Full Text] [Related]
4. Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy.
Wei L; Zhang Q; Zhong C; He L; Zhang Y; Armaly AM; Aubé J; Welch DR; Xu L; Wu X
Mol Oncol; 2023 Oct; 17(10):1962-1980. PubMed ID: 37357618
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration.
Muralidharan R; Babu A; Amreddy N; Basalingappa K; Mehta M; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
J Nanobiotechnology; 2016 Jun; 14(1):47. PubMed ID: 27328938
[TBL] [Abstract][Full Text] [Related]
6. The ATR inhibition by Elimusertib enhances the radiosensitivity of MDA-MB-231 triple negative breast cancer in vitro.
Guney Eskiler G; Halis H; Hamarat KF; Derlioglu RR; Ugurlu BT; Haciefendi A
Int J Radiat Biol; 2024; 100(5):715-723. PubMed ID: 38421209
[TBL] [Abstract][Full Text] [Related]
7. BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer.
Sriramulu S; Thoidingjam S; Chen WM; Hassan O; Siddiqui F; Brown SL; Movsas B; Green MD; Davis AJ; Speers C; Walker E; Nyati S
bioRxiv; 2024 May; ():. PubMed ID: 38766122
[TBL] [Abstract][Full Text] [Related]
8. PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation.
Zhang L; Bailleul J; Yazal T; Dong K; Sung D; Dao A; Gosa L; Nathanson D; Bhat K; Duhachek-Muggy S; Alli C; Dratver MB; Pajonk F; Vlashi E
Breast Cancer Res Treat; 2019 Nov; 178(1):75-86. PubMed ID: 31372790
[TBL] [Abstract][Full Text] [Related]
9. Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer.
Su YH; Wu YZ; Ann DK; Chen JL; Kuo CY
Cell Death Dis; 2023 Jan; 14(1):53. PubMed ID: 36681663
[TBL] [Abstract][Full Text] [Related]
10. Multiple suppressing small interfering RNA for cancer treatment-Application to triple-negative breast cancer.
Lee J; Bang JH; Ryu YC; Hwang BH
Biotechnol J; 2023 Nov; 18(11):e2300060. PubMed ID: 37478121
[TBL] [Abstract][Full Text] [Related]
11. Ginger-Derived 3HDT Exerts Antiproliferative Effects on Breast Cancer Cells by Apoptosis and DNA Damage.
Chen CY; Chen YN; Shiau JP; Tang JY; Hou MF; Chang HW
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982818
[TBL] [Abstract][Full Text] [Related]
12. 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation.
Skaripa-Koukelli I; Hauton D; Walsby-Tickle J; Thomas E; Owen J; Lakshminarayanan A; Able S; McCullagh J; Carlisle RC; Vallis KA
Cancer Metab; 2021 Oct; 9(1):37. PubMed ID: 34649623
[TBL] [Abstract][Full Text] [Related]
13. HuR (ELAVL1) Stabilizes
Morillo-Bernal J; Pizarro-García P; Moreno-Bueno G; Cano A; Mazón MJ; Eraso P; Portillo F
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254873
[TBL] [Abstract][Full Text] [Related]
14. HuR-dependent SOD2 protein synthesis is an early adaptation to anchorage-independence.
Kim YS; Tang PW; Welles JE; Pan W; Javed Z; Elhaw AT; Mythreye K; Kimball SR; Hempel N
Redox Biol; 2022 Jul; 53():102329. PubMed ID: 35594792
[TBL] [Abstract][Full Text] [Related]
15. YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways.
Andrade D; Mehta M; Griffith J; Panneerselvam J; Srivastava A; Kim TD; Janknecht R; Herman T; Ramesh R; Munshi A
Oncotarget; 2017 Nov; 8(58):98495-98508. PubMed ID: 29228705
[TBL] [Abstract][Full Text] [Related]
16. Phytoagent deoxyelephantopin derivative inhibits triple negative breast cancer cell activity by inducing oxidative stress-mediated paraptosis-like cell death.
Shiau JY; Nakagawa-Goto K; Lee KH; Shyur LF
Oncotarget; 2017 Aug; 8(34):56942-56958. PubMed ID: 28915644
[TBL] [Abstract][Full Text] [Related]
17. High Glucose Increases DNA Damage and Elevates the Expression of Multiple DDR Genes.
Rahmoon MA; Elghaish RA; Ibrahim AA; Alaswad Z; Gad MZ; El-Khamisy SF; Elserafy M
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672885
[TBL] [Abstract][Full Text] [Related]
18. Low-Dose Ionizing Radiation-Crosslinking Immunoprecipitation (LDIR-CLIP) Identified Irradiation-Sensitive RNAs for RNA-Binding Protein HuR-Mediated Decay.
Lee JW; Mun H; Kim JH; Ko S; Kim YK; Shim MJ; Kim K; Ho CW; Park HB; Kim M; Lee C; Choi SH; Kim JW; Jeong JH; Yoon JH; Min KW; Son TG
Biology (Basel); 2023 Dec; 12(12):. PubMed ID: 38132359
[TBL] [Abstract][Full Text] [Related]
19. The role of peroxiredoxin II in chemoresistance of breast cancer cells.
Wang T; Diaz AJ; Yen Y
Breast Cancer (Dove Med Press); 2014; 6():73-80. PubMed ID: 24976757
[TBL] [Abstract][Full Text] [Related]
20. Tackling the HuRdle of radioresistance: a radiation perspective on the RNA-binding protein HuR.
Troschel FM; Eich HT; Greve B
Transl Cancer Res; 2023 Dec; 12(12):3223-3226. PubMed ID: 38192977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
